Skip to content
  • News
  • Contact us
  • Careers
  •  
    • Kedrion Corporate
    • Kedrion S.P.A
    • Kedrion Biopharma GmbH
    • Kedrion Biopharma – Austria
    • Kedrion Biopharma – Portugal
    • Kedrion Biopharma – Poland
    • Kedrion Biopharma – Switzerland
    • Kedrion Biopharma – Russia
    • HUMAN Bioplazma Kft
    • Kedrion Mexicana S.A.
    • Kedrion de Colombia
    • Kedrion Betaphar
    • KEDPLASMA USA
    • RhoGAM
    • Koate
    • Gammaked
    • Albuked
    • KEDRAB
  •  
  •   
    • Linkedin
  • Kedrion Betaphar
  • About us
    • Corporate Structure
    • Annual Report
    • Corporate Social Responsibility
      • Environment, Health & Safety
      • Supporting our people
      • Support to communities
  • Expertise
    • Activities
    • Medical & Scientific Information
    • Product Development
    • Quality & Safety
  • Therapies
    • Therapeutic areas
      • Hematology/Hemophilia
      • Immunology/Neurology
      • Critical care
    • Business Partners
  • Services
    • Italian partnership
    • Contract manufacturing
    • Technology transfer
    • Biological Safety Center
  • Donors
    • Plasma
  • Pharmacovigilance
Find in Kedrion

NEWS


  • CORPORATE
  • EVENTS

Kedrion Biopharma set for strong presence at 2016 IgNS Meeting

Sep 13, 2016 | CORPORATE

Kedrion Biopharma will be a bronze sponsor at the Immunoglobulin National Society (IgNS) 2016 5th National Conference

Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin

Sep 01, 2016 | CORPORATE

Kamada and Kedrion, collaborators on development and commercialization of post-exposure treatment for suspected rabies, announced today the filing of a BLA with the FDA.

Kedrion Biopharma to attend 14th International Symposium of GBS/CIPD Foundation

Aug 22, 2016 | CORPORATE

Kedrion Biopharma will be a Silver Sponsor at the 14th International Symposium of GBS/CIPD Foundation

KEDPLASMA USA opens 13th center in the United States

Jun 06, 2016 | CORPORATE

KEDPLASMA USA, a Kedrion Biopharma company, has announced the opening of a new plasma collection center in Gastonia, NC.

Kedrion Biopharma extends its focus on patients by offering Mix2Vial

Mar 28, 2016 | CORPORATE

A needle-free, double-ended, all plastic filter transfer set for use in reconstituting Koate®-DVI

CURhE, Global Alliance for mother and child healthcare

Mar 08, 2016 | CORPORATE

Kedrion among the founding members with a goal of Rh disease eradication

Kedrion Biopharma Expands Immunoglobulin Therapies Portfolio

Jan 19, 2016 | CORPORATE

Gains Commercial Rights in the U.S. to BIVIGAM®, a Recently Approved IGIV Brand

KEDPlasma welcomes donors to its new Augsburg collection center

Jul 19, 2015 | CORPORATE

Plasma collected in Germany is essential to Kedrion Biopharma’s European plasma-derived therapies

Tuscany Italy adopts revolutionary PID testing

Jul 12, 2015 | EVENTS

Kedrion S.p.A. at Meyer Hospital’s side to promote early diagnosis of primary immunodeficiencies

Humanitarian programme augments access to clotting factors in developing countries

Jun 28, 2015 | CORPORATE

Kedrion helps the WISH project come true: Italian CNS[NM1] and the World Federation of Hemophilia sign agreement in London

Posts navigation

Previous 1 2 3 4 5 Next

Kedrion

Kedrion Biopharma Inc.
All rights reserved.
Dec 2019 CO-0109-11-2019
INTENDED FOR US AUDIENCES ONLY

INFORMATION

  • Privacy Statement
  • Terms of Use
  • Site map

HIGHLIGHTS

  • Annual Declaration of Compliance for the State of California
  • Code of Ethics and Code of Conduct

Where We Are

© 2023 Kedrion Biopharma Inc.

You are now leaving www.kedrion.us Medical information including licensed uses may be different outside of USA. Are you sure?

Kedrion usLogo Header Menu
    • About us
      • Corporate Structure
      • Annual Report
      • Corporate Social Responsibility
        • Environment, Health & Safety
        • Supporting our people
        • Support to communities
    • Expertise
      • Activities
      • Medical & Scientific Information
      • Product Development
      • Quality & Safety
    • Therapies
      • Therapeutic areas
        • Hematology/Hemophilia
        • Immunology/Neurology
        • Critical care
      • Business Partners
    • Services
      • Italian partnership
      • Contract manufacturing
      • Technology transfer
      • Biological Safety Center
    • Donors
      • Plasma
    • Pharmacovigilance
  • News
  • Contact Us
  • Careers
  • Kedrion’s Sites
    • Kedrion Corporate
    • Kedrion S.p.A
    • Kedrion Biopharma GmbH
    • Kedrion Biopharma – Austria
    • Kedrion Biopharma – Portugal
    • Kedrion Biopharma – Poland
    • Kedrion Biopharma – Switzerland
    • Kedrion Biopharma – Russia
    • HUMAN Bioplazma Kft
    • Kedrion Mexicana S.A.
    • Kedrion Betaphar
    • KEDPLASMA USA
    • RhoGAM
    • Koate
    • Gammaked
    • Albuked
    • KEDRAB
  • Social Network
    • Linkedin